LIDOCAINE 5%

LIDOCAINE 5% was reported 557 times

LIDOCAINE 5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOXYHAEMOGLOBINAEMIA 1 0.0769
1 BENIGN DUODENAL NEOPLASM 1 0.0769
2 RADICAL NECK DISSECTION 1 0.0625
3 INJECTION SITE JOINT REDNESS 1 0.0588
4 TRIGEMINAL PALSY 2 0.0435
5 INFILTRATION ANAESTHESIA 1 0.0312
6 GASTRIC ULCER SURGERY 1 0.0250
7 PELVIC FLOOR DYSSYNERGIA 1 0.0238
8 BLOOD METHAEMOGLOBIN PRESENT 2 0.0180
9 INJECTION SITE JOINT SWELLING 1 0.0179
10 OROPHARYNGEAL DISCOLOURATION 1 0.0172
11 BRONCHIAL INJURY 1 0.0172
12 FASCIAL RUPTURE 1 0.0169
13 BRONCHOALVEOLAR LAVAGE 1 0.0164
14 MENINGEAL NEOPLASM 1 0.0149
15 DURAL TEAR 1 0.0128
16 BURKHOLDERIA INFECTION 1 0.0120
17 PLATELET AGGREGATION INHIBITION 1 0.0109
18 CENTRAL NERVOUS SYSTEM MASS 1 0.0105
19 CARDIAC INDEX DECREASED 1 0.0097
20 MONONEUROPATHY 2 0.0096
21 MENINGITIS CHEMICAL 2 0.0091
22 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
23 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 1 0.0072
24 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
25 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
26 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
27 ADAMS-STOKES SYNDROME 1 0.0065
28 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
29 SERUM SEROTONIN DECREASED 1 0.0063
30 PNEUMOCEPHALUS 2 0.0060
31 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
32 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
33 CARDIAC PROCEDURE COMPLICATION 3 0.0049
34 GRAM STAIN POSITIVE 1 0.0049
35 GENITAL DISORDER MALE 1 0.0047
36 PARALYSIS FLACCID 1 0.0046
37 NEUROMUSCULAR BLOCKADE 1 0.0045
38 ANAESTHETIC COMPLICATION 12 0.0045
39 FAMILIAL PERIODIC PARALYSIS 1 0.0044
40 ANTERIOR CHAMBER DISORDER 1 0.0043
41 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
42 MENINGITIS FUNGAL 1 0.0043
43 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
44 DENTURE WEARER 1 0.0039
45 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
46 SYRINGOMYELIA 1 0.0036
47 WRONG PRODUCT STORED 1 0.0035
48 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
49 MONARTHRITIS 1 0.0033
50 HAEMORRHOIDS THROMBOSED 1 0.0033
51 INTESTINAL FUNCTIONAL DISORDER 2 0.0032
52 URTICARIA GENERALISED 2 0.0031
53 INTRACRANIAL HYPOTENSION 2 0.0031
54 UNWANTED AWARENESS DURING ANAESTHESIA 1 0.0030
55 SOFT TISSUE INFLAMMATION 1 0.0030
56 JOINT ABSCESS 1 0.0029
57 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
58 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 3 0.0028
59 SERUM SEROTONIN INCREASED 1 0.0028
60 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
61 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
62 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
63 SOFT TISSUE HAEMORRHAGE 1 0.0027
64 CAUDA EQUINA SYNDROME 2 0.0026
65 ADMINISTRATION SITE REACTION 1 0.0026
66 TRACHEOMALACIA 1 0.0025
67 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
68 SPUTUM CULTURE POSITIVE 2 0.0025
69 SPINAL DECOMPRESSION 1 0.0024
70 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
71 CORNEAL OEDEMA 5 0.0022
72 ANAESTHETIC COMPLICATION NEUROLOGICAL 2 0.0022
73 IMPLANT SITE REACTION 1 0.0022
74 RETINAL SCAR 1 0.0022
75 CHONDROLYSIS 1 0.0021
76 TUMOUR INVASION 1 0.0021
77 BRAIN STEM STROKE 1 0.0020
78 CATARACT OPERATION COMPLICATION 1 0.0020
79 TRACHEAL DISORDER 1 0.0019
80 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
81 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
82 ENZYME ABNORMALITY 1 0.0019
83 PRODUCT CLOSURE ISSUE 1 0.0018
84 NERVE ROOT COMPRESSION 1 0.0017
85 METHAEMOGLOBINAEMIA 4 0.0017
86 SPINAL EPIDURAL HAEMATOMA 1 0.0017
87 THALAMIC INFARCTION 1 0.0017
88 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
89 BLADDER IRRITATION 1 0.0016
90 ANOXIC ENCEPHALOPATHY 1 0.0016
91 IATROGENIC INJURY 2 0.0016
92 DEVICE BATTERY ISSUE 1 0.0015
93 GALLBLADDER PAIN 1 0.0015
94 INFUSION SITE URTICARIA 1 0.0015
95 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
96 ARTHRITIS BACTERIAL 6 0.0015
97 FLUID IMBALANCE 1 0.0014
98 SCROTAL OEDEMA 1 0.0014
99 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
100 SMALL FIBRE NEUROPATHY 1 0.0014
101 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
102 BRAIN STEM SYNDROME 1 0.0013
103 CHOLANGITIS ACUTE 1 0.0013
104 REFLUX OESOPHAGITIS 1 0.0013
105 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
106 IMPLANT SITE EXTRAVASATION 1 0.0013
107 LABORATORY TEST INTERFERENCE 1 0.0013
108 OPHTHALMOPLEGIA 2 0.0013
109 DEVICE DAMAGE 1 0.0013
110 ELECTROMECHANICAL DISSOCIATION 1 0.0013
111 ANAL ULCER 1 0.0012
112 CHEMICAL INJURY 1 0.0012
113 PERIORBITAL HAEMATOMA 1 0.0012
114 AMAUROSIS 1 0.0012
115 COLONIC ABSCESS 1 0.0012
116 INJECTION SITE OEDEMA 2 0.0012
117 ADENOMA BENIGN 1 0.0012
118 RECALLED PRODUCT 2 0.0012
119 SPINAL CORD INJURY 2 0.0011
120 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
121 IMPLANT SITE PRURITUS 1 0.0011
122 MUSCLE SWELLING 1 0.0011
123 EXTENSOR PLANTAR RESPONSE 1 0.0011
124 PRODUCT APPEARANCE CONFUSION 1 0.0011
125 HAEMOCHROMATOSIS 1 0.0011
126 PRODUCT SHAPE ISSUE 1 0.0011
127 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
128 CEREBELLAR ATAXIA 1 0.0010
129 SKIN TEXTURE ABNORMAL 1 0.0010
130 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
131 HEMIANOPIA 1 0.0010
132 CREPITATIONS 3 0.0010
133 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
134 IMPLANT SITE SWELLING 1 0.0010
135 INJECTION SITE NECROSIS 2 0.0010
136 BRAIN STEM INFARCTION 1 0.0010
137 CONJUNCTIVAL OEDEMA 1 0.0010
138 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
139 NEUROMYOPATHY 1 0.0009
140 ABSCESS LIMB 4 0.0009
141 DEVICE INEFFECTIVE 1 0.0009
142 INFUSION SITE MASS 1 0.0009
143 OCULAR TOXICITY 1 0.0009
144 NEPHROSCLEROSIS 1 0.0009
145 OPEN WOUND 1 0.0009
146 CATHETER RELATED COMPLICATION 1 0.0009
147 VITH NERVE PARALYSIS 1 0.0009
148 PUPILS UNEQUAL 1 0.0009
149 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
150 SICK SINUS SYNDROME 1 0.0009
151 ADMINISTRATION SITE PAIN 1 0.0009
152 CHEMICAL BURN 1 0.0009
153 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
154 AORTIC THROMBOSIS 1 0.0009
155 LUMBAR RADICULOPATHY 1 0.0009
156 RECTAL ULCER 1 0.0009
157 HYPERTENSIVE EMERGENCY 1 0.0008
158 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
159 CHRONIC RESPIRATORY FAILURE 1 0.0008
160 PANCREATIC NEOPLASM 1 0.0008
161 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
162 BREECH PRESENTATION 1 0.0008
163 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
164 LIP DISCOLOURATION 1 0.0008
165 EXCORIATION 2 0.0008
166 BRONCHIAL SECRETION RETENTION 1 0.0008
167 PROCEDURAL COMPLICATION 6 0.0008
168 FEELINGS OF WORTHLESSNESS 1 0.0008
169 URETERIC OBSTRUCTION 1 0.0007
170 INTESTINAL MASS 1 0.0007
171 PELVIC VENOUS THROMBOSIS 1 0.0007
172 FOOT AMPUTATION 1 0.0007
173 PRODUCT LABEL CONFUSION 4 0.0007
174 NODAL RHYTHM 1 0.0007
175 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
176 HYPERTHERMIA MALIGNANT 1 0.0007
177 IMPETIGO 1 0.0007
178 ENDOPHTHALMITIS 4 0.0007
179 ADHESION 1 0.0007
180 HEAT STROKE 1 0.0007
181 INFECTIOUS PLEURAL EFFUSION 1 0.0007
182 MYOGLOBIN BLOOD INCREASED 1 0.0007
183 INJECTION SITE PARAESTHESIA 1 0.0007
184 HUMERUS FRACTURE 3 0.0006
185 CRYPTOCOCCOSIS 1 0.0006
186 DENTAL IMPLANTATION 1 0.0006
187 THROMBOSIS IN DEVICE 2 0.0006
188 INJECTION RELATED REACTION 1 0.0006
189 QUADRIPARESIS 1 0.0006
190 DRUG TOXICITY 8 0.0006
191 PRODUCT COUNTERFEIT 1 0.0006
192 VASCULAR PSEUDOANEURYSM 1 0.0006
193 MENINGITIS CRYPTOCOCCAL 1 0.0006
194 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
195 TYPE I HYPERSENSITIVITY 2 0.0006
196 MUSCLE CRAMP 1 0.0006
197 PARAPARESIS 1 0.0006
198 CARDIAC ABLATION 1 0.0006
199 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
200 OPHTHALMIC HERPES ZOSTER 1 0.0006
201 ESSENTIAL HYPERTENSION 1 0.0005
202 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
203 BLOOD BICARBONATE DECREASED 1 0.0005
204 MYELOPATHY 1 0.0005
205 HYPOREFLEXIA 1 0.0005
206 POST PROCEDURAL COMPLICATION 10 0.0005
207 TRAUMATIC LUNG INJURY 1 0.0005
208 ATROPHY 1 0.0005
209 DIPLEGIA 1 0.0005
210 CORONARY ARTERY THROMBOSIS 1 0.0005
211 SINUS TACHYCARDIA 7 0.0005
212 VASCULAR STENT THROMBOSIS 1 0.0005
213 QUADRIPLEGIA 1 0.0005
214 NEUROGENIC BLADDER 1 0.0005
215 OCULOGYRIC CRISIS 1 0.0005
216 HYPERPHOSPHATAEMIA 1 0.0005
217 EXOPHTHALMOS 1 0.0005
218 METASTATIC NEOPLASM 2 0.0005
219 NOSOCOMIAL INFECTION 1 0.0005
220 RETROPERITONEAL HAEMATOMA 1 0.0005
221 BACTERIAL TEST POSITIVE 1 0.0004
222 PERIARTHRITIS 1 0.0004
223 BRAIN OPERATION 1 0.0004
224 EYELID DISORDER 1 0.0004
225 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
226 IMPLANT SITE INFECTION 1 0.0004
227 ORAL SURGERY 1 0.0004
228 CONTRAST MEDIA REACTION 1 0.0004
229 LONG QT SYNDROME 1 0.0004
230 PRODUCT PACKAGING CONFUSION 1 0.0004
231 BRONCHITIS CHRONIC 1 0.0004
232 DERMAL CYST 1 0.0004
233 MUSCLE SPASTICITY 5 0.0004
234 APPLICATION SITE BURN 2 0.0004
235 DENTAL OPERATION 1 0.0004
236 PENIS DISORDER 1 0.0004
237 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
238 INJECTION SITE ABSCESS 1 0.0004
239 TACHYARRHYTHMIA 1 0.0004
240 CATHETER SITE HAEMORRHAGE 1 0.0004
241 RETINAL ARTERY OCCLUSION 1 0.0004
242 ENDODONTIC PROCEDURE 1 0.0004
243 HERNIA REPAIR 1 0.0004
244 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
245 HEPATITIS TOXIC 1 0.0004
246 LUNG OPACITY 1 0.0004
247 INJECTION SITE DISCHARGE 2 0.0004
248 GASTRIC PERFORATION 1 0.0004
249 HYPERAESTHESIA 3 0.0004
250 FAECALOMA 2 0.0004
251 SERUM SICKNESS 1 0.0004
252 LUNG CONSOLIDATION 1 0.0004
253 DIABETIC COMA 1 0.0004
254 ACUTE PULMONARY OEDEMA 2 0.0004
255 DERMATITIS CONTACT 4 0.0004
256 HYPERTONIA 2 0.0003
257 PARAPLEGIA 1 0.0003
258 HAEMOTHORAX 1 0.0003
259 EYELID OEDEMA 4 0.0003
260 STRESS CARDIOMYOPATHY 2 0.0003
261 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
262 LUMBAR SPINAL STENOSIS 1 0.0003
263 STRIDOR 1 0.0003
264 ENERGY INCREASED 2 0.0003
265 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
266 WRONG DRUG ADMINISTERED 3 0.0003
267 INFUSION SITE REACTION 1 0.0003
268 BLOOD CULTURE POSITIVE 1 0.0003
269 REBOUND ACID HYPERSECRETION 1 0.0003
270 FIBROSIS 1 0.0003
271 PORTAL HYPERTENSION 1 0.0003
272 SCOLIOSIS 2 0.0003
273 INVESTIGATION 1 0.0003
274 RESPIRATORY RATE DECREASED 1 0.0003
275 FOREIGN BODY IN THROAT 1 0.0003
276 INFUSION SITE PRURITUS 1 0.0003
277 SKIN EROSION 1 0.0003
278 PORTAL VEIN THROMBOSIS 1 0.0003
279 APPLICATION SITE VESICLES 2 0.0003
280 LIVER ABSCESS 1 0.0003
281 HYPOVENTILATION 1 0.0003
282 INJECTION SITE INFECTION 1 0.0003
283 DEAFNESS NEUROSENSORY 1 0.0003
284 INFUSION SITE HAEMORRHAGE 1 0.0003
285 VENTRICULAR TACHYCARDIA 5 0.0003
286 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
287 MENINGITIS 2 0.0003
288 EYELID PTOSIS 3 0.0003
289 DRY THROAT 3 0.0003
290 PRODUCT LABEL ISSUE 2 0.0003
291 ECCHYMOSIS 2 0.0003
292 LEFT VENTRICULAR FAILURE 1 0.0003
293 CERVICAL VERTEBRAL FRACTURE 1 0.0003
294 GRANULOMA 1 0.0003
295 EXTRASYSTOLES 2 0.0003
296 HANGOVER 1 0.0003
297 LOGORRHOEA 1 0.0003
298 THERMAL BURN 2 0.0003
299 RETINAL HAEMORRHAGE 2 0.0003
300 CARDIOGENIC SHOCK 4 0.0003
301 APPARENT DEATH 1 0.0003
302 DIPLOPIA 7 0.0003
303 NEURODERMATITIS 1 0.0003
304 HEPATIC STEATOSIS 5 0.0003
305 PARANASAL SINUS DISCOMFORT 1 0.0003
306 LOSS OF CONTROL OF LEGS 1 0.0003
307 ACIDOSIS 2 0.0003
308 CLAVICLE FRACTURE 1 0.0003
309 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
310 CARDIOPULMONARY FAILURE 1 0.0003
311 TORSADE DE POINTES 2 0.0003
312 RESPIRATORY ACIDOSIS 1 0.0003
313 SKIN ODOUR ABNORMAL 1 0.0003
314 CANDIDIASIS 1 0.0002
315 POST PROCEDURAL INFECTION 2 0.0002
316 STAPHYLOCOCCAL INFECTION 8 0.0002
317 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
318 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
319 INFUSION SITE ERYTHEMA 2 0.0002
320 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
321 POOR PERIPHERAL CIRCULATION 1 0.0002
322 FACIAL PARALYSIS 2 0.0002
323 PSEUDOMONAS INFECTION 2 0.0002
324 TEARFULNESS 1 0.0002
325 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
326 LUNG INFILTRATION 2 0.0002
327 ABDOMINAL ABSCESS 1 0.0002
328 PHYSICAL DISABILITY 1 0.0002
329 RESPIRATORY RATE INCREASED 2 0.0002
330 IMPLANT SITE PAIN 1 0.0002
331 PAPILLOEDEMA 1 0.0002
332 DRUG EFFECT DELAYED 1 0.0002
333 APPLICATION SITE PRURITUS 5 0.0002
334 GRAND MAL CONVULSION 2 0.0002
335 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
336 NEPHROGENIC ANAEMIA 1 0.0002
337 ARTHRITIS INFECTIVE 1 0.0002
338 MULTIPLE MYELOMA 1 0.0002
339 PERFORMANCE STATUS DECREASED 1 0.0002
340 SKIN ABRASION 1 0.0002
341 BRONCHOSPASM 3 0.0002
342 GESTATIONAL DIABETES 1 0.0002
343 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
344 APHAGIA 1 0.0002
345 VULVOVAGINAL PAIN 1 0.0002
346 ATELECTASIS 2 0.0002
347 GUILLAIN-BARRE SYNDROME 1 0.0002
348 GASTROENTERITIS 3 0.0002
349 BREATH SOUNDS ABNORMAL 1 0.0002
350 STAPHYLOCOCCAL SEPSIS 1 0.0002
351 HOSPICE CARE 2 0.0002
352 BLADDER DISORDER 2 0.0002
353 PULMONARY MASS 3 0.0002
354 ABDOMINAL TENDERNESS 1 0.0002
355 PROTEIN URINE PRESENT 1 0.0002
356 HEPATIC ENZYME ABNORMAL 1 0.0002
357 HYPOTONIA 2 0.0002
358 CORONARY ARTERY STENOSIS 1 0.0002
359 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
360 TOE AMPUTATION 1 0.0002
361 PRODUCT ADHESION ISSUE 7 0.0002
362 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
363 PHARYNGEAL OEDEMA 3 0.0002
364 FOETAL DEATH 1 0.0002
365 PARTIAL SEIZURES 1 0.0002
366 APPLICATION SITE ERYTHEMA 5 0.0002
367 PRODUCT USE COMPLAINT 3 0.0002
368 BLOOD LACTIC ACID INCREASED 1 0.0002
369 SERUM FERRITIN INCREASED 1 0.0002
370 NYSTAGMUS 1 0.0002
371 PHARYNGOLARYNGEAL PAIN 1 0.0002
372 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
373 FOOD POISONING 1 0.0002
374 COMPRESSION FRACTURE 1 0.0002
375 ANAL ABSCESS 1 0.0002
376 HYDROCEPHALUS 1 0.0002
377 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
378 URINARY RETENTION 6 0.0002
379 NECROSIS 1 0.0002
380 PREMATURE LABOUR 1 0.0002
381 PERONEAL NERVE PALSY 1 0.0002
382 GENERALISED ERYTHEMA 1 0.0002
383 SCAR 3 0.0002
384 EXERCISE TOLERANCE DECREASED 1 0.0002
385 HYPERVENTILATION 1 0.0002
386 SKIN WARM 1 0.0002
387 CAESAREAN SECTION 2 0.0002
388 HYPOVOLAEMIA 1 0.0002
389 HYPERTRIGLYCERIDAEMIA 1 0.0002
390 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
391 MUSCLE RIGIDITY 2 0.0002
392 INJECTION SITE VESICLES 1 0.0002
393 NEURALGIA 4 0.0002
394 DERMATITIS ACNEIFORM 1 0.0002
395 DRUG ABUSER 1 0.0002
396 INJECTION SITE EXTRAVASATION 2 0.0002
397 DRUG DIVERSION 1 0.0002
398 CHOLANGITIS 1 0.0002
399 OLIGURIA 1 0.0002
400 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
401 ILEUS 2 0.0002
402 INFUSION SITE EXTRAVASATION 1 0.0002
403 NASAL DRYNESS 1 0.0002
404 PHOTOPHOBIA 3 0.0002
405 MUSCLE ATROPHY 2 0.0002
406 SCREAMING 1 0.0002
407 INTRAOCULAR PRESSURE INCREASED 2 0.0002
408 MYDRIASIS 2 0.0002
409 INFUSION SITE PAIN 2 0.0002
410 HIATUS HERNIA 2 0.0002
411 TENDON DISORDER 1 0.0002
412 BRADYCARDIA 8 0.0002
413 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
414 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
415 BREAST MASS 1 0.0001
416 METASTASES TO LYMPH NODES 1 0.0001
417 SINUS CONGESTION 2 0.0001
418 WRONG PRODUCT ADMINISTERED 1 0.0001
419 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
420 INFARCTION 1 0.0001
421 PERIPHERAL COLDNESS 2 0.0001
422 APPLICATION SITE RASH 2 0.0001
423 DEFAECATION URGENCY 1 0.0001
424 HALLUCINATION, VISUAL 3 0.0001
425 HYPOXIA 5 0.0001
426 SKIN REACTION 2 0.0001
427 RETCHING 3 0.0001
428 IMPAIRED WORK ABILITY 3 0.0001
429 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
430 LETHARGY 8 0.0001
431 VISUAL FIELD DEFECT 1 0.0001
432 APPLICATION SITE PAIN 3 0.0001
433 SENSITIVE SKIN 1 0.0001
434 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
435 RESPIRATORY DISORDER 4 0.0001
436 HYDRONEPHROSIS 1 0.0001
437 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
438 HAEMODYNAMIC INSTABILITY 1 0.0001
439 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
440 MUSCLE TWITCHING 3 0.0001
441 RENAL FAILURE CHRONIC 1 0.0001
442 ATRIOVENTRICULAR BLOCK 1 0.0001
443 LUNG INFECTION 2 0.0001
444 EJECTION FRACTION DECREASED 2 0.0001
445 APNOEA 1 0.0001
446 SWOLLEN TONGUE 4 0.0001
447 HAEMORRHAGIC STROKE 1 0.0001
448 GASTROINTESTINAL INFLAMMATION 1 0.0001
449 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
450 CYANOSIS 2 0.0001
451 MEDICATION ERROR 7 0.0001
452 LOW BIRTH WEIGHT BABY 1 0.0001
453 ABSCESS 2 0.0001
454 MIOSIS 1 0.0001
455 SENSORY LOSS 1 0.0001
456 RHINITIS 1 0.0001
457 MUSCLE DISORDER 1 0.0001
458 BLOOD POTASSIUM INCREASED 2 0.0001
459 DECUBITUS ULCER 1 0.0001
460 CONVULSION 7 0.0001
461 ABNORMAL FAECES 1 0.0001
462 CARDIAC ARREST 10 0.0001
463 MENSTRUAL DISORDER 1 0.0001
464 EMBOLISM 1 0.0001
465 FACE OEDEMA 2 0.0001
466 INADEQUATE ANALGESIA 1 0.0001
467 CIRCULATORY COLLAPSE 2 0.0001
468 CARDIAC OPERATION 1 0.0001
469 UNRESPONSIVE TO STIMULI 3 0.0001
470 ANURIA 1 0.0001
471 SKIN ULCER 3 0.0001
472 BLOOD MAGNESIUM DECREASED 1 0.0001
473 MULTI-ORGAN FAILURE 2 0.0001
474 ORTHOSTATIC HYPOTENSION 2 0.0001
475 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
476 NEUROTOXICITY 2 0.0001
477 GROIN PAIN 1 0.0001
478 SPINAL OSTEOARTHRITIS 1 0.0001
479 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
480 GOUT 2 0.0001
481 LOSS OF LIBIDO 1 0.0001
482 ANAL INCONTINENCE 1 0.0001
483 PALLOR 3 0.0001
484 CRYING 4 0.0001
485 HYPOTENSION 22 0.0001
486 END STAGE RENAL DISEASE 2 0.0001
487 EXOSTOSIS 1 0.0001
488 ACCIDENTAL OVERDOSE 4 0.0001
489 RESPIRATORY ARREST 3 0.0001
490 OXYGEN SATURATION DECREASED 6 0.0001
491 LACERATION 1 0.0001
492 DYSARTHRIA 4 0.0001
493 SQUAMOUS CELL CARCINOMA 1 0.0001
494 RECALLED PRODUCT ADMINISTERED 1 0.0001
495 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
496 HYPERSOMNIA 3 0.0001
497 SEROTONIN SYNDROME 2 0.0001
498 ACUTE RESPIRATORY FAILURE 2 0.0001
499 SINUS BRADYCARDIA 1 0.0001
500 DYSTONIA 2 0.0001
501 AUTOIMMUNE DISORDER 1 0.0001
502 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
503 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
504 VITREOUS FLOATERS 1 0.0001
505 THERAPY CHANGE 1 0.0001
506 URINARY INCONTINENCE 3 0.0001
507 INABILITY TO AFFORD MEDICATION 1 0.0001
508 PERITONITIS BACTERIAL 1 0.0001
509 MOTOR DYSFUNCTION 1 0.0001
510 SINUSITIS 10 0.0001
511 THERAPY CESSATION 5 0.0001
512 VENTRICULAR EXTRASYSTOLES 1 0.0001
513 PULMONARY HYPERTENSION 2 0.0001
514 TENDERNESS 1 0.0001
515 WEIGHT FLUCTUATION 1 0.0001
516 AGITATION 7 0.0001
517 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
518 HEAD INJURY 3 0.0001
519 JOINT DISLOCATION 1 0.0001
520 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
521 NIGHT SWEATS 3 0.0001
522 DRUG EFFECT DECREASED 5 0.0001
523 PULMONARY THROMBOSIS 1 0.0001
524 OSTEONECROSIS 3 0.0001
525 ASPIRATION 1 0.0001
526 BLOOD GLUCOSE FLUCTUATION 1 0.0001
527 VISUAL ACUITY REDUCED 3 0.0001
528 VENTRICULAR FIBRILLATION 1 0.0001
529 NERVE INJURY 1 0.0001
530 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
531 IMPAIRED DRIVING ABILITY 1 0.0001
532 SCAB 1 0.0001
533 MICTURITION URGENCY 1 0.0001
534 ELECTROLYTE IMBALANCE 1 0.0001
535 ATAXIA 1 0.0001
536 BACTERAEMIA 1 0.0001
537 THYROID CANCER 1 0.0001
538 LOCALISED INFECTION 2 0.0001
539 ADRENAL INSUFFICIENCY 1 0.0001
540 HYPERGLYCAEMIA 3 0.0001
541 FIBROMYALGIA 2 0.0001
542 PRESYNCOPE 2 0.0001
543 NO THERAPEUTIC RESPONSE 1 0.0001
544 ENCEPHALOPATHY 2 0.0001
545 CARDIOMEGALY 1 0.0001
546 HYPERCALCAEMIA 1 0.0001
547 HEART RATE INCREASED 8 0.0001
548 APPLICATION SITE IRRITATION 1 0.0001
549 INJECTION SITE DISCOLOURATION 1 0.0001
550 DYSPNOEA EXERTIONAL 3 0.0001
551 DERMATITIS ALLERGIC 1 0.0001
552 BRAIN OEDEMA 1 0.0001
553 INJECTION SITE IRRITATION 1 0.0001
554 ROTATOR CUFF SYNDROME 1 0.0001
555 ANOREXIA 1 0.0001
556 ANAPHYLACTIC SHOCK 2 0.0001
557 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
558 NODULE 1 0.0001
559 GASTRITIS 2 0.0001
560 TOOTH INFECTION 1 0.0001
561 PULMONARY CONGESTION 1 0.0001
562 DRUG INTERACTION 12 0.0001
563 EAR INFECTION 2 0.0001
564 QUALITY OF LIFE DECREASED 1 0.0001
565 MOOD ALTERED 2 0.0001
566 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
567 HAEMATOCHEZIA 4 0.0001
568 ANAPHYLACTIC REACTION 4 0.0001
569 POLLAKIURIA 3 0.0001
570 COORDINATION ABNORMAL 1 0.0001
571 MASS 1 0.0001
572 WITHDRAWAL SYNDROME 3 0.0001
573 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
574 BLINDNESS UNILATERAL 1 0.0001
575 LYMPHOPENIA 1 0.0001
576 HEPATOCELLULAR INJURY 1 0.0001
577 PARALYSIS 1 0.0001
578 IMPAIRED QUALITY OF LIFE 1 0.0001
579 PARAESTHESIA ORAL 1 0.0001
580 SEIZURE 8 0.0001
581 HYPOKINESIA 1 0.0001
582 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
583 CARDIOMYOPATHY 1 0.0001
584 RENAL INJURY 2 0.0001
585 PULMONARY OEDEMA 3 0.0001
586 HAEMORRHAGE INTRACRANIAL 1 0.0001
587 THROAT IRRITATION 3 0.0001
588 BLOOD POTASSIUM DECREASED 2 0.0001
589 HYPOAESTHESIA ORAL 1 0.0001
590 APHASIA 2 0.0001
591 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
592 OSTEOPENIA 1 0.0001
593 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
594 PLEURAL EFFUSION 4 0.0001
595 DRUG DISPENSING ERROR 1 0.0001
596 INSURANCE ISSUE 1 0.0001
597 TINNITUS 3 0.0001
598 HIP ARTHROPLASTY 1 0.0001
599 INJECTION SITE RASH 2 0.0001
600 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
601 ANKLE FRACTURE 1 0.0001
602 CARDIAC DISORDER 6 0.0001
603 BASAL CELL CARCINOMA 1 0.0001
604 PREMATURE DELIVERY 1 0.0001
605 OBESITY 1 0.0001
606 METABOLIC ACIDOSIS 2 0.0001
607 SENSORY DISTURBANCE 1 0.0001
608 MOVEMENT DISORDER 2 0.0001
609 MUSCLE TIGHTNESS 1 0.0001
610 DRY MOUTH 5 0.0001
611 MUSCULAR WEAKNESS 7 0.0001
612 SWELLING FACE 4 0.0001
613 BLOOD CREATININE INCREASED 4 0.0001
614 IMPAIRED HEALING 2 0.0001
615 MANIA 1 0.0001
616 MUSCLE SPASMS 11 0.0001
617 BLOOD UREA INCREASED 1 0.0001
618 CHILLS 7 0.0001
619 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
620 DISEASE PROGRESSION 7 0.0001
621 HEMIPARESIS 1 0.0001
622 PRODUCT QUALITY ISSUE 8 0.0001
623 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
624 BLOOD PRESSURE INCREASED 9 0.0001
625 ERYTHEMA 12 0.0001
626 ABDOMINAL PAIN UPPER 12 0.0001
627 INFLAMMATION 3 0.0001
628 BALANCE DISORDER 5 0.0001
629 NERVOUSNESS 3 0.0001
630 LOCAL SWELLING 1 0.0001
631 MUSCULOSKELETAL PAIN 3 0.0001
632 SPEECH DISORDER 3 0.0001
633 BURNING SENSATION 4 0.0001
634 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
635 TACHYCARDIA 5 0.0001
636 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
637 ISCHAEMIC STROKE 1 0.0001
638 GALLBLADDER DISORDER 1 0.0001
639 OSTEOMYELITIS 1 0.0001
640 BONE DISORDER 1 0.0001
641 LOSS OF CONSCIOUSNESS 7 0.0001
642 HYPERHIDROSIS 7 0.0001
643 TREMOR 9 0.0001
644 SEPSIS 6 0.0001
645 BACTERIAL INFECTION 1 0.0001
646 COLITIS 2 0.0001
647 DYSPHAGIA 5 0.0001
648 BLOOD URINE PRESENT 1 0.0001
649 GASTRIC ULCER 1 0.0001
650 PROTEINURIA 1 0.0001
651 FEELING JITTERY 1 0.0001
652 SLEEP APNOEA SYNDROME 1 0.0001
653 PRODUCT SUBSTITUTION ISSUE 3 0.0001
654 CHOLESTASIS 1 0.0001
655 DRUG PRESCRIBING ERROR 1 0.0001
656 PYREXIA 18 0.0001
657 HERNIA 1 0.0001
658 ERUCTATION 1 0.0001
659 ATRIAL FIBRILLATION 5 0.0001
660 PALPITATIONS 6 0.0001
661 PARAESTHESIA 8 0.0001
662 SINUS DISORDER 1 0.0001
663 DISORIENTATION 2 0.0001
664 DIZZINESS 25 0.0001
665 SPINAL FRACTURE 1 0.0000
666 FEEDING DISORDER 1 0.0000
667 TASTE DISORDER 1 0.0000
668 VERTIGO 3 0.0000
669 BLINDNESS 2 0.0000
670 BODY TEMPERATURE INCREASED 1 0.0000
671 FEELING HOT 3 0.0000
672 PRODUCT PREPARATION ERROR 1 0.0000
673 RIB FRACTURE 1 0.0000
674 INJECTION SITE WARMTH 1 0.0000
675 INFLUENZA LIKE ILLNESS 4 0.0000
676 HYPERSENSITIVITY 9 0.0000
677 PERITONITIS 1 0.0000
678 NAUSEA 38 0.0000
679 RHABDOMYOLYSIS 2 0.0000
680 ABDOMINAL DISTENSION 5 0.0000
681 ROAD TRAFFIC ACCIDENT 2 0.0000
682 MOUTH ULCERATION 1 0.0000
683 BACK PAIN 11 0.0000
684 GAIT DISTURBANCE 9 0.0000
685 EATING DISORDER 1 0.0000
686 IRRITABLE BOWEL SYNDROME 1 0.0000
687 HYPOACUSIS 2 0.0000
688 PRURITUS GENERALISED 1 0.0000
689 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
690 DEVICE DISLOCATION 2 0.0000
691 SEPTIC SHOCK 2 0.0000
692 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
693 MUSCULOSKELETAL STIFFNESS 4 0.0000
694 PAIN 28 0.0000
695 MELAENA 1 0.0000
696 FEBRILE NEUTROPENIA 3 0.0000
697 BLOOD PRESSURE DECREASED 3 0.0000
698 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
699 TOOTH DISORDER 1 0.0000
700 THROMBOCYTOPENIA 5 0.0000
701 VOMITING 21 0.0000
702 ORAL PAIN 1 0.0000
703 HEADACHE 28 0.0000
704 SNEEZING 1 0.0000
705 PANCREATITIS ACUTE 1 0.0000
706 HEART RATE IRREGULAR 1 0.0000
707 SKIN IRRITATION 2 0.0000
708 SKIN DISCOLOURATION 2 0.0000
709 SHOCK 1 0.0000
710 CONFUSIONAL STATE 7 0.0000
711 PERICARDIAL EFFUSION 1 0.0000
712 CHEST PAIN 8 0.0000
713 COGNITIVE DISORDER 2 0.0000
714 ARRHYTHMIA 2 0.0000
715 COMA 2 0.0000
716 RASH ERYTHEMATOUS 2 0.0000
717 MULTIPLE SCLEROSIS 2 0.0000
718 URTICARIA 7 0.0000
719 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
720 DIABETIC KETOACIDOSIS 1 0.0000
721 TOXICITY TO VARIOUS AGENTS 7 0.0000
722 INFECTION 6 0.0000
723 INTERSTITIAL LUNG DISEASE 2 0.0000
724 INJECTION SITE URTICARIA 1 0.0000
725 BRONCHITIS 3 0.0000
726 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
727 INJECTION SITE ERYTHEMA 5 0.0000
728 HYPOAESTHESIA 6 0.0000
729 PNEUMONIA ASPIRATION 1 0.0000
730 LEUKOPENIA 2 0.0000
731 CELLULITIS 2 0.0000
732 UNEVALUABLE EVENT 3 0.0000
733 HAEMATEMESIS 1 0.0000
734 FLUSHING 4 0.0000
735 COUGH 11 0.0000
736 INJECTION SITE SWELLING 3 0.0000
737 HEPATITIS 1 0.0000
738 FALL 13 0.0000
739 PERIPHERAL SWELLING 6 0.0000
740 RASH GENERALISED 1 0.0000
741 HAEMATOMA 1 0.0000
742 MUCOSAL INFLAMMATION 1 0.0000
743 SEDATION 1 0.0000
744 ARTHRITIS 3 0.0000
745 HYPERTENSION 8 0.0000
746 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
747 JAUNDICE 1 0.0000
748 PAIN OF SKIN 1 0.0000
749 DISTURBANCE IN ATTENTION 2 0.0000
750 BLOOD BILIRUBIN INCREASED 1 0.0000
751 THROAT TIGHTNESS 1 0.0000
752 RASH PRURITIC 2 0.0000
753 OEDEMA 2 0.0000
754 LIMB INJURY 1 0.0000
755 CONSTIPATION 8 0.0000
756 RESPIRATORY DISTRESS 1 0.0000
757 ABNORMAL DREAMS 1 0.0000
758 DIVERTICULITIS 1 0.0000
759 PROCEDURAL PAIN 1 0.0000
760 MENTAL STATUS CHANGES 1 0.0000
761 FEELING COLD 1 0.0000
762 INFLUENZA 4 0.0000
763 PANCYTOPENIA 2 0.0000
764 NECK PAIN 2 0.0000
765 WOUND 1 0.0000
766 SKIN EXFOLIATION 3 0.0000
767 URINARY TRACT INFECTION 6 0.0000
768 PANCREATIC CARCINOMA 1 0.0000
769 ASTHENIA 13 0.0000
770 LIVER FUNCTION TEST ABNORMAL 1 0.0000
771 DYSSTASIA 1 0.0000
772 NASAL CONGESTION 2 0.0000
773 ACUTE MYOCARDIAL INFARCTION 1 0.0000
774 LABORATORY TEST ABNORMAL 1 0.0000
775 WHEEZING 2 0.0000
776 FEELING ABNORMAL 8 0.0000
777 PREMATURE BABY 1 0.0000
778 HEPATIC FAILURE 1 0.0000
779 LACRIMATION INCREASED 1 0.0000
780 CORONARY ARTERY DISEASE 1 0.0000
781 INJECTION SITE PAIN 10 0.0000
782 DRUG ADMINISTRATION ERROR 1 0.0000
783 FEMUR FRACTURE 1 0.0000
784 WEIGHT DECREASED 9 0.0000
785 EXPOSURE DURING PREGNANCY 2 0.0000
786 BONE DENSITY DECREASED 1 0.0000
787 PULMONARY EMBOLISM 3 0.0000
788 CYSTITIS 1 0.0000
789 PAIN IN EXTREMITY 9 0.0000
790 EYE DISORDER 1 0.0000
791 DECREASED APPETITE 7 0.0000
792 EXPIRED PRODUCT ADMINISTERED 1 0.0000
793 VIRAL INFECTION 1 0.0000
794 FUNGAL INFECTION 1 0.0000
795 SYNCOPE 3 0.0000
796 GAIT INABILITY 1 0.0000
797 INJECTION SITE PRURITUS 2 0.0000
798 SOMNOLENCE 6 0.0000
799 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
800 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
801 GASTRIC DISORDER 1 0.0000
802 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
803 INJECTION SITE REACTION 2 0.0000
804 DELIRIUM 1 0.0000
805 HEART RATE DECREASED 1 0.0000
806 SLEEP DISORDER 2 0.0000
807 LYMPHADENOPATHY 1 0.0000
808 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
809 OVERDOSE 6 0.0000
810 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
811 PANIC ATTACK 1 0.0000
812 RESPIRATORY FAILURE 2 0.0000
813 DYSURIA 1 0.0000
814 NASOPHARYNGITIS 5 0.0000
815 DYSGEUSIA 2 0.0000
816 EPISTAXIS 2 0.0000
817 DRUG INEFFECTIVE 35 0.0000
818 ASTHMA 3 0.0000
819 ACUTE KIDNEY INJURY 4 0.0000
820 PRURITUS 10 0.0000
821 FATIGUE 20 0.0000
822 PLASMA CELL MYELOMA 1 0.0000
823 ALOPECIA 5 0.0000
824 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
825 PNEUMONIA 8 0.0000
826 LUNG NEOPLASM MALIGNANT 1 0.0000
827 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
828 CARDIO-RESPIRATORY ARREST 1 0.0000
829 RECTAL HAEMORRHAGE 1 0.0000
830 CONDITION AGGRAVATED 7 0.0000
831 MENTAL DISORDER 1 0.0000
832 DYSPNOEA 13 0.0000
833 ANGIOEDEMA 1 0.0000
834 RENAL FAILURE 3 0.0000
835 DRY SKIN 3 0.0000
836 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
837 ADVERSE DRUG REACTION 2 0.0000
838 VISION BLURRED 3 0.0000
839 MEMORY IMPAIRMENT 3 0.0000
840 NEPHROLITHIASIS 1 0.0000
841 HYPOKALAEMIA 1 0.0000
842 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
843 OROPHARYNGEAL PAIN 2 0.0000
844 BLOOD CHOLESTEROL INCREASED 1 0.0000
845 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
846 OCULAR HYPERAEMIA 1 0.0000
847 DISEASE RECURRENCE 1 0.0000
848 ANAEMIA 4 0.0000
849 MIGRAINE 2 0.0000
850 PRODUCTIVE COUGH 1 0.0000
851 CONTUSION 2 0.0000
852 RASH 9 0.0000
853 HYPOGLYCAEMIA 1 0.0000
854 OFF LABEL USE 18 0.0000
855 DYSPEPSIA 2 0.0000
856 DRY EYE 1 0.0000
857 AGGRESSION 1 0.0000
858 FLUID RETENTION 1 0.0000
859 HOSPITALISATION 3 0.0000
860 HAEMORRHAGE 2 0.0000
861 ECZEMA 1 0.0000
862 INSOMNIA 5 0.0000
863 ARTHROPATHY 1 0.0000
864 ABDOMINAL DISCOMFORT 3 0.0000
865 BLISTER 1 0.0000
866 EYE PAIN 1 0.0000
867 CEREBROVASCULAR ACCIDENT 3 0.0000
868 FLATULENCE 1 0.0000
869 ANXIETY 5 0.0000
870 ABDOMINAL PAIN 4 0.0000
871 BONE PAIN 1 0.0000
872 SURGERY 1 0.0000
873 DIARRHOEA 11 0.0000
874 IRRITABILITY 1 0.0000
875 JOINT SWELLING 2 0.0000
876 STOMATITIS 1 0.0000
877 OEDEMA PERIPHERAL 2 0.0000
878 MALAISE 7 0.0000
879 RHINORRHOEA 1 0.0000
880 DEEP VEIN THROMBOSIS 1 0.0000
881 INFUSION RELATED REACTION 1 0.0000
882 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
883 NEUTROPENIA 2 0.0000
884 ARTHRALGIA 6 0.0000
885 INJURY 1 0.0000
886 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
887 THERAPY INTERRUPTED 1 0.0000
888 SKIN BURNING SENSATION 1 0.0000
889 WEIGHT INCREASED 3 0.0000
890 HALLUCINATION 1 0.0000
891 ACNE 1 0.0000
892 CHRONIC KIDNEY DISEASE 1 0.0000
893 INCORRECT DOSE ADMINISTERED 3 0.0000
894 DEATH 11 0.0000
895 CARDIAC FAILURE 1 0.0000
896 THROMBOSIS 1 0.0000
897 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
898 MYALGIA 2 0.0000
899 MYOCARDIAL INFARCTION 2 0.0000
900 INTENTIONAL PRODUCT MISUSE 1 0.0000
901 DRUG WITHDRAWAL SYNDROME 1 0.0000
902 DEVICE ISSUE 1 0.0000
903 NO ADVERSE EVENT 2 0.0000
904 ADVERSE EVENT 1 0.0000
905 SWELLING 1 0.0000
906 PRODUCT USE ISSUE 2 0.0000
907 DRUG INTOLERANCE 1 0.0000
908 CHEST DISCOMFORT 1 0.0000
909 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
910 HAEMOGLOBIN DECREASED 1 0.0000
911 ILLNESS 1 0.0000
912 PLATELET COUNT DECREASED 1 0.0000
913 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
914 EMOTIONAL DISTRESS 1 0.0000
915 VISUAL IMPAIRMENT 1 0.0000
916 DEHYDRATION 1 0.0000
917 DRUG DOSE OMISSION 1 0.0000
918 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
919 BLOOD GLUCOSE INCREASED 1 0.0000
920 DEPRESSION 1 0.0000